Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of SGLT2 Inhibitors on Renal Anemia and Its Management in Patients With CKD in Japan

NCT07063316 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT07063316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07063316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of SGLT2 Inhibitors on Renal Anemia and Its Management in Patients With CKD in Japan
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Active, not recruiting
Start date
July 23, 2025
Completion date
December 25, 2026
Enrollment
15,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease